Consumer
Year: 2025
News Feed
Canadian Gold Corp. Doubles the Phase 4 Drill Program at Tartan Mine Following McEwen Mining Investment
Flin Flon, Manitoba–(Newsfile Corp. – April 10, 2025) – Canadian Gold Corp. (TSXV: CGC) (“Canadian Gold” or the “Company“) is pleased to announce its plans to double the size of its Phase 4 drill program […]
News Feed
Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens
VANCOUVER & DALLAS, April 10, 2025–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Robert Wills, […]
Featured Interviews
Canadian Gold Corp. (TSXV: CGC) (OTC: STRRF)(8S8:FRA)
Interview with Michael Swistun, President & CEO […]
Featured Interviews
Alpha Cognition Inc. (NASDAQ: ACOG)
Interview with Michael McFadden, CEO […]
Featured Interviews
Soligenix (NASDAQ: SNGX) Interview with Christopher Schaber, PhD CEO and President
Interview with Christopher Schaber, PhD CEO and President […]
Featured Interviews
Kobrea Exploration Corp. (CSE: KBX) (OTCQB: KBXFF)
Interview with Rory Ritchie, VP of Exploration […]
News Feed
Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants
Broader protection induced by combination of COVID adenovirus vaccine plus CiVax™ compared to 2-shot mRNA vaccination series PRINCETON, N.J., March 25, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on […]
News Feed
Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview
Conference Call Scheduled for March 31, 2025 4:30pm ET VANCOUVER, British Columbia & DALLAS, March 19, 2025–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that […]